Table 2. Agreement at the CD4 clinical cutoff of 200 cells/μL.
Reagent | Systems | FACSCanto II (Cells/μL) | Agreement | Percent (%) | 95% CL (LCLd, UCLe) | ||
---|---|---|---|---|---|---|---|
BD FACSLyric (Cells/μL) | Positive (≤200) |
Negative (>200) |
Total | ||||
IMK | Positive (≤200) | 85 | 2 | 87 | Overall | 98.9 | 97.2, 99.6 |
Negative (>200) | 2 | 273 | 275 | Positive | 97.7 | 92.0, 99.4 | |
Total | 87 | 275 | 362 | Negative | 99.3 | 97.4, 99.8 | |
6-Color TBNK | Positive (≤200) | 71 | 0 | 71 | Overall | 99.1 | 97.3, 99.7 |
Negative (>200) | 3 | 243 | 246 | Positive | 96.0 | 88.8, 98.6 | |
Total | 74 | 243 | 317 | Negative | 100 | 98.4, 100.0 |
dlower confidence limit
eupper confidence limit.